Lutris Pharma
Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
About
Technology stack
detected 2026-05-25No comments yet. Be the first to share your take.
What does Lutris Pharma do?
Lutris Pharma is a clinical-stage biotechnology company dedicated to developing transformative therapies for patients with rare genetic diseases. The company leverages its proprietary platform to identify and advance novel drug candidates with the potential to address significant unmet medical needs.
How much funding has Lutris Pharma raised?
Lutris Pharma has raised a total of $170M in funding. The most recent round on record is Series A.
Where is Lutris Pharma headquartered?
Lutris Pharma is headquartered in San Diego, United States.
When was Lutris Pharma founded?
Lutris Pharma was founded in 2017.
What industry does Lutris Pharma operate in?
Lutris Pharma operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Rare Diseases.
What is Lutris Pharma's current status?
Lutris Pharma's current operating status is: Inactive.